Valuation: EUROAPI

Market Cap 131M 150M 120M 112M 212M 14.24B 216M 1.44B 561M 7B 562M 550M 24.13B P/E 2026 *
-1.72x
P/E 2027 * -3.25x
Enterprise Value 89.13M 102M 81.91M 76.35M 145M 9.71B 147M 983M 382M 4.77B 383M 374M 16.44B EV / Sales 2026 *
0.12x
EV / Sales 2027 * 0.16x
Free-Float
65.03%
Yield 2026 *
-
Yield 2027 * -
1 day-2.58%
1 month-2.58%
3 months-2.58%
6 months-42.59%
Current year-42.59%
1 month 1.51
Extreme 1.51
1.51
Current year 1.27
Extreme 1.27
2.54
1 year 1.27
Extreme 1.27
3.74
3 years 1.27
Extreme 1.27
12.7
5 years 1.27
Extreme 1.27
23.4
10 years 1.27
Extreme 1.27
23.4
Manager TitleAgeSince
Chief Executive Officer - 08/12/2024
Director of Finance/CFO - 16/10/2024
Compliance Officer - 26/11/2023
Director TitleAgeSince
Director/Board Member 62 05/05/2022
Director/Board Member - 05/05/2022
Chairman 57 08/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
-2.58%-.--% - - 150M
+1.86%+0.48%+55.50%+163.08% 1,082B
+3.57%+3.29%+68.60%+61.03% 633B
+3.99%+3.05%+37.93%+93.37% 461B
+3.86%+1.64%+32.57%+24.89% 338B
-0.56%+0.96%+41.67%+39.35% 299B
-0.08%+1.30%+32.15%+44.48% 291B
-1.54%+2.81%-25.35%-39.61% 222B
+3.55%+4.41%+25.45%+66.28% 202B
+4.21%+2.65%+17.47%+71.11% 163B
Average +1.63%+4.58%+31.78%+58.22% 410.27B
Weighted average by Cap. +2.24%+5.53%+42.31%+83.31%

Financials

2026 *2027 *
Net sales 760M 870M 699M 651M 1.24B 82.83B 1.25B 8.39B 3.26B 40.71B 3.27B 3.2B 140B 782M 894M 718M 670M 1.27B 85.13B 1.29B 8.62B 3.35B 41.84B 3.36B 3.28B 144B
Net income -75.7M -86.59M -69.57M -64.85M -123M -8.25B -125M -835M -325M -4.05B -325M -318M -13.97B -40.25M -46.05M -36.99M -34.48M -65.4M -4.38B -66.39M -444M -173M -2.16B -173M -169M -7.43B
Net Debt -41.66M -47.66M -38.29M -35.69M -67.69M -4.54B -68.72M -460M -179M -2.23B -179M -175M -7.69B -5.06M -5.79M -4.65M -4.34M -8.23M -551M -8.35M -55.86M -21.72M -271M -21.74M -21.27M -934M
Logo EUROAPI
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 5 production sites located in France (2), Germany, Italy and Hungary.
Employees
2,961
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
4
Last Close Price
1.374EUR
Average target price
1.475EUR
Spread / Average Target
+7.35%

Quarterly revenue - Rate of surprise